StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.51−0.24 (-13.71%)

Close on Nov 17, 2026Market cap $12.07MP/E –Yield –

PAVmed gross margin

Gross margin is gross profit as a percentage of revenue.

PAVmed's gross margin for the twelve months ending Jun 30, 2026 was -220.5%. For fiscal 2025 it was -207.0%, against -61.6% the year before. The highest annual figure on record is -17.0% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-207.0%−145.4
FY2024Dec 31, 2024-61.6%+100.2
FY2023Dec 31, 2023-161.8%+696.8
FY2022Dec 31, 2022-858.6%−841.6
FY2021Dec 31, 2021-17.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-269.7%+313.6
Q1 FY2026Mar 31, 2026-340.9%+9.1
Q4 FY2025Dec 31, 2025-63.5%+316.5
Q3 FY2025Sep 30, 2025-1000.0%−961.3
Q2 FY2025Jun 30, 2025-583.3%−513.2
Q1 FY2025Mar 31, 2025-350.0%−277.3
Q4 FY2024Dec 31, 2024-380.0%−326.4
Q3 FY2024Sep 30, 2024-38.7%+86.3
Q2 FY2024Jun 30, 2024-70.2%+844.9
Q1 FY2024Mar 31, 2024-72.7%+129.1
Q4 FY2023Dec 31, 2023-53.6%+1291.1
Q3 FY2023Sep 30, 2023-124.9%+1914.6
Q2 FY2023Jun 30, 2023-915.1%−819.8
Q1 FY2023Mar 31, 2023-201.8%−154.8
Q4 FY2022Dec 31, 2022-1344.6%−1372.6
Q3 FY2022Sep 30, 2022-2039.5%–
Q1 FY2022Mar 31, 2022-95.2%–
Q4 FY2021Dec 31, 2021-47.0%–
Q3 FY2021Sep 30, 202128.0%–

More PAVmed figures

See a number that looks wrong?